Novel Cinobufagin Oxime Ether Derivatives as Potential Na+/ K+-ATPase Inhibitors: Synthesis, Biological Screening and Molecular Docking | |
Liang Guangping[1,2]; Chung Tseyu[3]; Guo Jinhua[1,2]; Zhang Rongrong[1,2]; Xu Wei[1,2]; Tzen, Jason T. C.[3]; Jiang Renwang[1,2] | |
2017 | |
卷号 | 33期号:3页码:378 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4756276 |
专题 | 暨南大学 |
作者单位 | 1.[1]Jinan Univ, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Jinan Univ, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou 510632, Guangdong, Peoples R China 3.[3]Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan |
推荐引用方式 GB/T 7714 | Liang Guangping[1,2],Chung Tseyu[3],Guo Jinhua[1,2],et al. Novel Cinobufagin Oxime Ether Derivatives as Potential Na+/ K+-ATPase Inhibitors: Synthesis, Biological Screening and Molecular Docking[J],2017,33(3):378. |
APA | Liang Guangping[1,2].,Chung Tseyu[3].,Guo Jinhua[1,2].,Zhang Rongrong[1,2].,Xu Wei[1,2].,...&Jiang Renwang[1,2].(2017).Novel Cinobufagin Oxime Ether Derivatives as Potential Na+/ K+-ATPase Inhibitors: Synthesis, Biological Screening and Molecular Docking.,33(3),378. |
MLA | Liang Guangping[1,2],et al."Novel Cinobufagin Oxime Ether Derivatives as Potential Na+/ K+-ATPase Inhibitors: Synthesis, Biological Screening and Molecular Docking".33.3(2017):378. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论